{"id":36048,"date":"2019-04-30T09:00:26","date_gmt":"2019-04-30T09:00:26","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=36048"},"modified":"2019-12-06T09:59:08","modified_gmt":"2019-12-06T09:59:08","slug":"htb-30-april-2019-vol-20-no-5-bhiva-and-croi-reports","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/36048","title":{"rendered":"HTB 30 April 2019: vol 20 no 5 \u2013 BHIVA and CROI reports"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-36049\" src=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/04\/HTB-30-Apr-2019-cover-210x300.png\" alt=\"\" width=\"210\" height=\"300\" srcset=\"https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/04\/HTB-30-Apr-2019-cover-210x300.png 210w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/04\/HTB-30-Apr-2019-cover-768x1096.png 768w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/04\/HTB-30-Apr-2019-cover-718x1024.png 718w, https:\/\/i-base.info\/htb\/wp-content\/uploads\/2019\/04\/HTB-30-Apr-2019-cover.png 1142w\" sizes=\"auto, (max-width: 210px) 100vw, 210px\" \/><\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/i-base.info\/htb\/date\/2019\/04\">Contents online<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/htb\/36055\" rel=\"noopener noreferrer\">PDF of this issue<\/a><\/li>\n<li><a href=\"https:\/\/i-base.info\/forms\/esub.php\">Subscribe by email<\/a><\/li>\n<\/ul>\n<p><strong>Welcome to the fifth issue of HTB this year, where our first report from the BHIVA 2019 spring conference covers the pre-conference workshop on U=U that included a presentation from the campaign founder Bruce Richman.<\/strong><\/p>\n<p>A key discussion point was the growing consensus that, in the context of good adherence, U=U starts from the first undetectable viral load result. This means there is no longer a need for people to wait for six months before assuming the transmission risk is zero.<\/p>\n<p>Continued reports from CROI cover three topics in depth. These are broadly neutralising antibodies (bNAbs), a paediatric update on dolutegravir and other cure research (excluding the UK remission case we have already reported).<\/p>\n<p>This issue also includes pipeline news that the option for injectable ART moves a step closer with submission of cabotegravir\/rilpivirine LA injections to the FDA (EMA to follow shortly) and that the US have already approved dolutegravir\/lamivudine as a dual therapy combination (tradename Dovato).<\/p>\n<p>Finally, UK news that a new branch of cliniQ is opening in South London to cover sexual health for trans communities.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Contents online PDF of this issue Subscribe by email Welcome to the fifth issue of HTB this year, where our first report from the BHIVA 2019 spring conference covers the pre-conference workshop on U=U that included a presentation from the &hellip;<\/p>\n","protected":false},"author":3,"featured_media":36068,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-36048","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-editorial"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=36048"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/36048\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media\/36068"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=36048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=36048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=36048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}